Patrick W Serruys

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Coronary stents: historical development, current status and future directions
    Javaid Iqbal
    Thorax Centre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Br Med Bull 106:193-211. 2013
  2. doi Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study
    Robert M A van der Boon
    Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Thorac Surg 97:22-8. 2014
  3. ncbi Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:947-53. 2005
  4. ncbi Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:455-60. 2004
  5. doi Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:584-94. 2010
  6. doi Incidence, timing, and predictors of valve dislodgment during TAVI with the Medtronic Corevalve System
    Nicolas M Van Mieghem
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 79:726-32. 2012
  7. doi Assessment of the aortic annulus by multislice computed tomography, contrast aortography, and trans-thoracic echocardiography in patients referred for transcatheter aortic valve implantation
    Apostolos Tzikas
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 77:868-75. 2011
  8. doi Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis
    Carl Schultz
    Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 7:564-72. 2011
  9. ncbi Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
    Ron T van Domburg
    Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 5:962-7. 2010
  10. doi Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy
    Joanna J Wykrzykowska
    Department of Interventional Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:861-70. 2009

Collaborators

Detail Information

Publications65

  1. ncbi Coronary stents: historical development, current status and future directions
    Javaid Iqbal
    Thorax Centre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Br Med Bull 106:193-211. 2013
    ..This article describes the history of coronary angioplasty and stenting, reviews the contemporary stents and recommendations and highlights the on-going work and potential future directions...
  2. doi Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study
    Robert M A van der Boon
    Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Thorac Surg 97:22-8. 2014
    ..Therefore, the aim of this study was to compare the short-term and midterm outcomes of TA-AVI versus TF-AVI...
  3. ncbi Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:947-53. 2005
    ....
  4. ncbi Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:455-60. 2004
    ..13 +/- 0.34 and restenosis rate was 7.7%. Although not routinely recommended in every patient, SES postdilatation with largely oversized balloons appears a safe and effective strategy for selected patients...
  5. doi Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:584-94. 2010
    ....
  6. doi Incidence, timing, and predictors of valve dislodgment during TAVI with the Medtronic Corevalve System
    Nicolas M Van Mieghem
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 79:726-32. 2012
    ..To determine the incidence, timing and predictors of periprocedural valve dislodgment with the Medtronic Corevalve System (MCS)...
  7. doi Assessment of the aortic annulus by multislice computed tomography, contrast aortography, and trans-thoracic echocardiography in patients referred for transcatheter aortic valve implantation
    Apostolos Tzikas
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 77:868-75. 2011
    ....
  8. doi Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis
    Carl Schultz
    Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 7:564-72. 2011
    ..We compared the measurement of aortic leaflet calcification on contrast and non-contrast MSCT and investigated predictors of the need for balloon post-dilatation after TAVI...
  9. ncbi Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
    Ron T van Domburg
    Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 5:962-7. 2010
    ....
  10. doi Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy
    Joanna J Wykrzykowska
    Department of Interventional Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:861-70. 2009
    ..We assessed the impact of vessel size on outcomes of stenting with biolimus-eluting degradable polymer stent (BES) and sirolimus-eluting permanent polymer stent (SES) within a randomized multicenter trial (LEADERS)...
  11. ncbi Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry
    Joost Daemen
    The Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 98:895-901. 2006
    ..The beneficial effects, reported after 1 and 2 years in reducing major adverse cardiac events, persisted with no evidence of a clinical late restenotic "catch-up" phenomenon...
  12. doi Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus
    Takashi Muramatsu
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 6:247-57. 2013
    ..The aim of this study was to investigate the incidence and clinical sequelae of small side branch occlusion (SBO) after Absorb (Abbott Vascular, Santa Clara, California) bioresorbable vascular scaffold (BVS) implantation...
  13. doi Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry
    Zhu jun Shen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 74:979-86. 2009
    ..The objective of this report was to evaluate the outcomes of these patients at 5-years clinical follow-up...
  14. pmc Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT
    Juan Luis Gutiérrez-Chico
    Erasmus Medical Centre, Thoraxcenter, Ba583a, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 28:467-78. 2012
    ..Volumetric calculations using solid state IVUS are therefore not reliable. There is poor agreement for MLA estimation between all the imaging modalities studied, including IVUS-OCT, hence their values are not interchangeable...
  15. doi Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation
    Rutger Jan M Nuis
    Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 77:881-9. 2011
    ....
  16. doi The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 8:1277-85. 2013
    ..A limitation of the SXscore is the inability to differentiate outcomes in patients who have undergone prior coronary artery bypass graft (CABG) surgery. The CABG SXscore was devised to address this limitation...
  17. doi 3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery)
    Chrysafios Girasis
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:41-8. 2010
    ..We explore the bifurcation angle (BA) parameters of the left main coronary artery (LM), the effect of percutaneous coronary intervention (PCI) on this angulation, and the impact of BA on clinical outcome...
  18. ncbi Compositional volumetry of non-calcified coronary plaques by multislice computed tomography: an ex vivo feasibility study
    Nico Bruining
    Department of Cardiology, Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    EuroIntervention 5:558-64. 2009
    ..This study explores the application to use the Hounsfield units (HU) distribution of coronary plaques imaged by multislice computed tomography-coronary angiography (MSCT-CA)...
  19. doi Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LE
    Joanna J Wykrzykowska
    Department of Interventional Cardiology Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 7:605-13. 2011
    ..The SYNTAX score (SXscore) has been shown to be an effective predictor of clinical outcomes in patients undergoing percutaneous coronary intervention (PCI)...
  20. doi Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease
    Cihan Simsek
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 76:41-9. 2010
    ..There are limited data on the long-term safety and efficacy profile of coronary stent implantation in patients with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI)...
  21. doi Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
    Josep Gomez-Lara
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 4:1271-80. 2011
    ..This study sought to compare the neointimal response of metallic everolimus drug-eluting stents (DES) and polymeric everolimus bioresorbable vascular scaffolds (BVS) by optical coherence tomography at 1 year...
  22. doi A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years
    Patrick W Serruys
    Department of Interventional Cardiology, Erasmus University, Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 5:606-17. 2012
    ....
  23. ncbi Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process
    Juan Luis Gutiérrez-Chico
    Interventional Cardiology Department, Erasmus Medical Centre, Thoraxcentre, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 5:428-35. 2012
    ....
  24. doi Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study
    Scot Garg
    Department of Interventional Cardiology, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:1060-7. 2011
    ....
  25. ncbi Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospit
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:603-10. 2009
    ..We investigated the impact of sex on outcomes after percutaneous coronary intervention (PCI) with drug-eluting stent (DES)...
  26. ncbi Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:2500-2. 2004
    ..We evaluated the clinical and angiographic outcomes of patients presenting with restenosis after sirolimus-eluting stent (SES) implantation treated with repeated percutaneous intervention...
  27. ncbi The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129)
    Joost Daemen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 4:464-74. 2009
    ..There is still limited data about the long-term safety and efficacy of DES in high-risk subgroups...
  28. ncbi Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries)
    Joost Daemen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 99:1027-32. 2007
    ..A high frequency of stent thrombosis was observed in the 2 drug-eluting stent groups...
  29. doi Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice
    Nicolas M Van Mieghem
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 6:867-75. 2013
    ....
  30. ncbi Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries)
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 96:358-62. 2005
    ..Patients who required insulin had a significantly higher, crude major adverse cardiac event rate at 1 year compared with those who used oral agents, but this rate became nonsignificant when adjusted for independent predictors of outcome...
  31. ncbi Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology
    Carlos A G van Mieghem
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 21:425-41. 2005
    ..It outlines the analyses that will be performed to compare invasive and non-invasive imaging techniques in conjunction with multiple biomarkers to characterize non-flow limiting subclinical coronary lesions...
  32. ncbi Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RES
    Marco Valgimigli
    Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 111:1383-9. 2005
    ..The impact of drug-eluting stent (DES) implantation on the incidence of major adverse cardiovascular events in patients undergoing percutaneous intervention for left main (LM) coronary disease is largely unknown...
  33. pmc Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
    Salvatore Brugaletta
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, s Gravendijkwal 230, 3015, Rotterdam, CE, The Netherlands
    Int J Cardiovasc Imaging 28:1307-14. 2012
    ..Larger studies are required to investigate the clinical impact of these findings...
  34. ncbi Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians
    Maniyal Vijayakumar
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 94:909-13. 2004
    ..SES implantation in octogenarians appears to be feasible and is associated with very small subsequent need for repeat target vessel revascularization at 1 year...
  35. doi Effect of body mass index on short- and long-term outcomes after transcatheter aortic valve implantation
    Robert M A van der Boon
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 111:231-6. 2013
    ..After adjustment, obesity was associated with a lower risk of 30-day mortality and had no adverse effect on mortality after discharge, underscoring the "obesity paradox" in patients undergoing TAVI...
  36. doi ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatm
    Roberto Diletti
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Am Heart J 164:654-63. 2012
    ..Currently, no data are available on the direct comparison between the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) and conventional metallic drug-eluting stents...
  37. ncbi Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments
    Salvatore Brugaletta
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circ J 76:1616-23. 2012
    ..Polymeric bioresorbable ABSORB scaffolds have less stiffness than metallic platform stents. We sought to analyze the mismatch in vascular compliance after ABSORB implantation and its long-term resolution with bioresorption...
  38. ncbi A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents
    Josep Gomez-Lara
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:1190-8. 2010
    ..The aim of this study was to assess the differences in terms of curvature and angulation of the treated vessel after the deployment of either a metallic stent or a polymeric scaffold device...
  39. ncbi One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries
    Gaston A Rodriguez-Granillo
    Cardiac Catheterization Laboratory, Thoraxcenter, Erasmus Medical Center, Rotterdam, Kamer Z 120, Dr Molewaterplein 40, Rotterdam, The Netherlands 3015 GD
    J Invasive Cardiol 17:409-12. 2005
    ..The efficacy of sirolimus-eluting stents (SES) compared to paclitaxel-eluting stents (PES) remains unknown. We evaluated the clinical outcomes after implantation of 2.25 mm diameter SES and PES...
  40. doi Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
    Salvatore Brugaletta
    Thoraxcenter, Erasmus MC, Ba 583, s Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 27:859-66. 2011
    ..33 vs. 6.36%, P = 0.2). Serial IVUS-VH analysis of BVS-treated lesions at 6-month demonstrated a progression in the NC and fibrous tissue content of PBS...
  41. ncbi Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical tri
    Hector M Garcia-Garcia
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 4:443-8. 2009
    ....
  42. ncbi Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study
    Francesco Saia
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 108:1927-9. 2003
    ..Sirolimus-eluting stents (SES) have recently been proven to reduce restenosis and reintervention compared with bare stents. Safety and effectiveness of SES in acute myocardial infarction remain unknown...
  43. ncbi Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era
    Emanuele Meliga
    Interventional Cardiology Department, Thoraxcenter, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 70:21-5. 2007
    ..To compare the postprocedural and long-term clinical outcomes of two groups of patients, all presenting with chronic saphenous vein graft (SVG) occlusion, who underwent either SVG or native vessel reopening...
  44. doi Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study
    Nico Bruining
    Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:449-56. 2010
    ....
  45. ncbi Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR
    Sharon W Kirschbaum
    Department of Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Imaging 3:614-22. 2010
    ....
  46. doi Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus
    Patrick W Serruys
    Thoraxcenter, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 6:777-89. 2013
    ..This study sought to report the final 5 years follow-up of the landmark LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) trial...
  47. doi Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, s Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands
    Eur Heart J 33:3098-104. 2012
    ..The incorporation of clinical factors may further augment the utility of the SXscore to longer-term risk stratify the individual patient for clinical outcomes...
  48. doi Changes in mitral regurgitation after transcatheter aortic valve implantation
    Apostolos Tzikas
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 75:43-9. 2010
    ..To assess the acute and intermediate changes in mitral regurgitation (MR) severity after transcatheter aortic valve implantation (TAVI) with the CoreValve Revalving SystemTM (CRS)...
  49. doi Trends in outcome after transfemoral transcatheter aortic valve implantation
    Nicolas M Van Mieghem
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am Heart J 165:183-92. 2013
    ..Our aim was to assess trends in outcome after TF-TAVI...
  50. doi Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds
    Bill D Gogas
    Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 6:211-21. 2013
    ..Our objective is to highlight the clinical importance of the EVR as a predisposing and contributing factor to device failure with either bare-metal stents, DES, or bioresorbable scaffolds...
  51. ncbi Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery
    Angela Hoye
    Department of Cardiology, Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands
    Coron Artery Dis 15:171-5. 2004
    ..We evaluated the impact of utilizing the sirolimus-eluting stent (SES) in this high-risk population...
  52. ncbi Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
    Angela Hoye
    Department of Interventional Cardiology, Erasmus MC, Rotterdam, The Netherlands
    J Am Coll Cardiol 43:1954-8. 2004
    ..The aim of this study was to assess sirolimus-eluting stent (SES) implantation for the treatment of chronic total coronary occlusions (CTO)...
  53. ncbi Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings
    Kengo Tanabe
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 94:115-8. 2004
    ..At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis...
  54. doi Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting
    Milena Soriano Marcolino
    Department of Cardiology, Erasmus MC, s Gravendijkwal 230, Rotterdam, The Netherlands
    EuroIntervention 8:920-8. 2012
    ..To investigate the incidence of cardiac events in octogenarians who underwent percutaneous coronary intervention (PCI) with stenting, as well as to evaluate the efficacy and safety of drug-eluting stents (DES) in this population...
  55. doi Strain distribution over plaques in human coronary arteries relates to shear stress
    Frank J H Gijsen
    Department of Biomedical Engineering, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Physiol Heart Circ Physiol 295:H1608-14. 2008
    ..Higher strain can be found in all other plaque regions, with the highest strain found in regions exposed to the highest shear stresses. This indicates that high shear stress might destabilize plaques, which could lead to plaque rupture...
  56. ncbi Computed tomography as a tool for percutaneous coronary intervention of chronic total occlusions
    Michael Magro
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 6:G123-31. 2010
    ..It is then that we can evaluate the true benefit of the use of MSCT for CTO against the risk from excessive radiation associated with this strategy...
  57. ncbi Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound
    Carlos A G van Mieghem
    Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circulation 114:645-53. 2006
    ..Multislice computed tomography (MSCT) is a promising technique for noninvasive coronary evaluation. We evaluated the diagnostic performance of high-resolution MSCT to detect ISR after stenting of the LMCA...
  58. doi Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction
    Apostolos Tzikas
    Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 107:285-9. 2011
    ..In conclusion, the induction of new conduction abnormalities after TAVI with the Medtronic-CoreValve was associated with a lack of improvement in LV systolic function...
  59. doi Left ventricular mass regression one year after transcatheter aortic valve implantation
    Apostolos Tzikas
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Thorac Surg 91:685-91. 2011
    ..The objective of this study was to investigate the degree of LV mass regression and the changes of LV diastolic function one year after transcatheter aortic valve implantation (TAVI)...
  60. doi Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent
    Yoshinobu Onuma
    Department of Interventional Cardiology, Thorax Center, Erasmus MC, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 78:3-12. 2011
    ..0 in ABSORB cohort A and the BVS revision 1.1 in ABSORB cohort B with the historical recoil of the XIENCE V® everolimus-eluting metal stent (EES, SPIRIT I and II)...
  61. ncbi The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:253-60. 2005
    ..The aim of this study was to evaluate the effect of variable dose and release kinetics of paclitaxel on neointimal hyperplasia...
  62. ncbi Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited
    Angela Hoye
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 7:36-40. 2005
    ..Drug-eluting stents reduce the rate of restenosis and need for repeat lesion revascularization compared with bare metal stents; we re-evaluated this technique with drug-eluting stent implantation...
  63. doi Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?
    Salvatore Brugaletta
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Atherosclerosis 221:106-12. 2012
    ..To quantify the circumferential healing process at 6 and 12 months following scaffold implantation...
  64. ncbi Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience
    Chourmouzios A Arampatzis
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 63:57-60. 2004
    ..6%. SES implantation for multivessel disease in a consecutive series of patients is associated with low incidence of adverse events. The reported results are related predominantly to the reduction in repeat revascularization...
  65. ncbi Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention
    Hector M Garcia-Garcia
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 4:607-16. 2009
    ..To define better the role of CTCA in the treatment of patients with CTOs, we performed CTCA in a consecutive cohort of eligible patients who were scheduled for percutaneous recanalisation of a CTO...